Hanumant Chouhan, Mohammad Ali Abbass, Jennifer E Hrabe, Sylvain Ferrandon, Jennifer DeVecchio, Gautam Mankaney, Carol A Burke, Brandie Heald, Lisa Ann LaGuardia, Margaret O'Malley, Susan Milicia, David Liska, James Church, Steven C Campbell, Matthew F Kalady
BACKGROUND: Approximately 5% to 10% of patients with Lynch syndrome develop urothelial carcinoma. Current screening recommendations vary and are based on expert opinion. Practices need to be evaluated for clinical effectiveness. Our program utilizes urinalysis as a screening test, followed by additional evaluation of microscopic hematuria. OBJECTIVE: This study aimed to determine the clinical utility of a urinalysis-based screening approach for urothelial cancers in patients with Lynch syndrome...
January 1, 2022: Diseases of the Colon and Rectum